These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 10736908)
21. Incidental atrial fibrillation and its management. Saliba W Postgrad Med; 2011 Mar; 123(2):27-35. PubMed ID: 21474890 [TBL] [Abstract][Full Text] [Related]
22. Stroke prevention in atrial fibrillation: are we following the guidelines? Pusser BE; Robertson SL; Robinson MD; Barton C; Dobson LA N C Med J; 2005; 66(1):9-13. PubMed ID: 15786672 [TBL] [Abstract][Full Text] [Related]
23. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. Flaker GC; McGowan DJ; Boechler M; Fortune G; Gage B Am Heart J; 1999 Feb; 137(2):307-12. PubMed ID: 9924165 [TBL] [Abstract][Full Text] [Related]
24. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative]. Själander A; Wallentin L; Rosenqvist M; Svensson P Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862 [No Abstract] [Full Text] [Related]
25. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention. Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823 [TBL] [Abstract][Full Text] [Related]
26. Stroke prevention in elderly patients with atrial fibrillation. Lew SJ; Lim JK Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065 [TBL] [Abstract][Full Text] [Related]
27. Evidence-based emergency medicine. Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. Diner BM Ann Emerg Med; 2003 Jan; 41(1):141-3. PubMed ID: 12514695 [No Abstract] [Full Text] [Related]
28. Atrial fibrillation and anticoagulation. Maxim R Med Health R I; 2001 Mar; 84(3):96-7. PubMed ID: 11280139 [No Abstract] [Full Text] [Related]
29. Stroke prevention in hospitalized patients with atrial fibrillation: a population-based study. Nagpal S; Anderson D; Putnam W; Flowerdew G; Gardner M; Cox J Can J Clin Pharmacol; 2003; 10(4):197-201. PubMed ID: 14712325 [TBL] [Abstract][Full Text] [Related]
30. Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation. Burkiewicz JS Pharmacotherapy; 2005 Aug; 25(8):1062-7. PubMed ID: 16207096 [TBL] [Abstract][Full Text] [Related]
32. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M; Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748 [TBL] [Abstract][Full Text] [Related]
33. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL; Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169 [TBL] [Abstract][Full Text] [Related]
34. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. Waldo AL; Becker RC; Tapson VF; Colgan KJ; J Am Coll Cardiol; 2005 Nov; 46(9):1729-36. PubMed ID: 16256877 [TBL] [Abstract][Full Text] [Related]
35. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation. Rockson SG; Albers GW J Am Coll Cardiol; 2004 Mar; 43(6):929-35. PubMed ID: 15028346 [TBL] [Abstract][Full Text] [Related]
36. A cautionary note on data sources for evidence-based clinical decisions: warfarin and stroke prevention. Thomson R; Eccles M; Wood R; Chinn DJ Med Decis Making; 2007; 27(4):438-47. PubMed ID: 17641140 [TBL] [Abstract][Full Text] [Related]
37. Antithrombotic therapy in atrial fibrillation. Garcia DA; Hylek EM Clin Geriatr Med; 2006 Feb; 22(1):155-66, x. PubMed ID: 16377472 [TBL] [Abstract][Full Text] [Related]
38. A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation. Jackson SL; Peterson GM; Vial JH Ann Pharmacother; 2004 Nov; 38(11):1794-9. PubMed ID: 15454583 [TBL] [Abstract][Full Text] [Related]
39. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ; Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203 [TBL] [Abstract][Full Text] [Related]
40. Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands--The EXAMINE-AF study. A questionnaire survey. Dinh T; Nieuwlaat R; Tieleman RG; Büller HR; van Charante NA; Prins MH; Crijns HJ Int J Clin Pract; 2007 Jan; 61(1):24-31. PubMed ID: 17229177 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]